Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PRSS1 | P07477 | 7/20 | 1.00 |
| ▸ | PRSS2 | P07478 | 3/20 | 1.00 |
| ▸ | PRSS3 | P35030 | 3/20 | 1.00 |
| ▸ | PTGIR | P43119 | 1/20 | 0.78 |
| ▸ | NQO2 | P16083 | 2/20 | 0.70 |
| ▸ | ST14 | Q9Y5Y6 | 3/20 | 0.67 |
| ▸ | F2 | P00734 | 2/20 | 0.67 |
| ▸ | PLAU | P00749 | 2/20 | 0.67 |
| ▸ | CA1 | P00915 | 1/20 | 0.61 |
| ▸ | CA2 | P00918 | 1/20 | 0.61 |
| ▸ | PARP1 | P09874 | 1/20 | 0.61 |
| ▸ | PARP10 | Q53GL7 | 1/20 | 0.61 |
| ▸ | PARP2 | Q9UGN5 | 1/20 | 0.61 |
| ▸ | PARP4 | Q9UKK3 | 1/20 | 0.61 |
| ▸ | TMPRSS2 | O15393 | 1/20 | 0.57 |
| ▸ | PRMT1 | Q99873 | 1/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL2570665 | 0.98 | PRSS1 (0.95) | PRSS1PRSS2PRSS3PTGIRNQO2 | |
| SCHEMBL15293729 | 0.94 | PRSS1 (0.88) | PRSS1PRSS2PRSS3PTGIRNQO2 | |
| SCHEMBL9852193 | 0.92 | PRSS1 (0.84) | PRSS1PRSS2PRSS3PTGIRNQO2 | |
| SCHEMBL9852190 | 0.90 | PRSS1 (0.81) | PRSS1PRSS2PRSS3PTGIRNQO2 | |
| SCHEMBL5788625 | 0.88 | PTGIR (1.00) | PRSS1PRSS2PRSS3PTGIRNQO2 | |
| SCHEMBL10890871 | 0.85 | PRSS1 (0.72) | PRSS1PRSS2PRSS3PTGIRNQO2 | |
| SCHEMBL14599566 | 0.84 | NQO2 (1.00) | PRSS1PRSS2PRSS3PTGIRNQO2 | |
| Hydrochloric Acid SCHEMBL30859643 | 0.82 | ALDH1A1 (0.74) | PRSS1PRSS2PRSS3PTGIRNQO2 | |
| SCHEMBL31546801 | 0.81 | PRSS1 (0.68) | PRSS1PRSS2PRSS3PTGIRNQO2 | |
| SCHEMBL3368290 | 0.81 | PRSS1 (0.68) | PRSS1PRSS2PRSS3PTGIRNQO2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 170 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250003975-A1 | Systems and Methods for Performing a Real-Time Glycan Assay of a Sample | AMGEN INC. (US) | 2025-01-02 | — | — | US | claimed |
| CN-110892267-B | System and method for real-time glycan determination of a sample | 安进公司 | 2024-08-09 | — | — | CN | claimed |
| EP-3662288-B1 | SYSTEMS AND METHODS FOR PERFORMING A REAL-TIME GLYCAN ASSAY OF A SAMPLE | AMGEN INC (US) | 2024-02-28 | — | — | EP | claimed |
| CN-113383039-B | Moisture curable polyolefin formulation | 陶氏环球技术有限责任公司 | 2023-09-26 | — | — | CN | claimed |
| US-20220098432-A1 | MOISTURE-CURABLE POLYOLEFIN FORMULATION | DOW GLOBAL TECHNOLOGIES LLC (US) | 2022-03-31 | — | — | US | claimed |
| EP-3924083-A1 | SYSTEMS AND METHODS FOR PREPARING A SAMPLE AND PERFORMING A REAL-TIME ASSAY OF THE SAMPLE | Amgen Inc. (US) | 2021-12-22 | — | — | EP | claimed |
| EP-3924419-A1 | MOISTURE-CURABLE POLYOLEFIN FORMULATION | Dow Global Technologies LLC (US) | 2021-12-22 | — | — | EP | claimed |
| CN-113383039-A | Moisture curable polyolefin formulations | 陶氏环球技术有限责任公司 | 2021-09-10 | — | — | CN | claimed |
| WO-2020164004-A1 | MOISTURE-CURABLE POLYOLEFIN FORMULATION | DOW GLOBAL TECHNOLOGIES LLC (US) | 2020-08-20 | — | — | WO | claimed |
| WO-2020168156-A1 | SYSTEMS AND METHODS FOR PREPARING A SAMPLE AND PERFORMING A REAL-TIME ASSAY OF THE SAMPLE | AMGEN INC. (US) | 2020-08-20 | — | — | WO | claimed |
| EP-3662288-A1 | SYSTEMS AND METHODS FOR PERFORMING A REAL-TIME GLYCAN ASSAY OF A SAMPLE | Amgen Inc. (US) | 2020-06-10 | — | — | EP | claimed |
| CN-110892267-A | Systems and methods for real-time glycan determination of a sample | 安进公司 | 2020-03-17 | — | — | CN | claimed |
| WO-2019028191-A9 | SYSTEMS AND METHODS FOR PERFORMING A REAL-TIME GLYCAN ASSAY OF A SAMPLE | AMGEN INC. (US) | 2020-01-09 | — | — | WO | claimed |
| WO-2019028191-A1 | SYSTEMS AND METHODS FOR PERFORMING A REAL-TIME GLYCAN ASSAY OF A SAMPLE | AMGEN INC. (US) | 2019-02-07 | — | — | WO | claimed |
| EP-4397977-B1 | SYSTEMS AND METHODS FOR PREPARING A SAMPLE AND PERFORMING A REAL-TIME ASSAY OF THE SAMPLE | AMGEN INC (US) | 2026-04-29 | — | — | EP | disclosed |
| US-12352755-B2 | Systems and methods for preparing a sample and performing a real-time assay of the sample | AMGEN INC. (US) | 2025-07-08 | — | — | US | disclosed |
| US-20250057957-A1 | SPIROCYCLIC DEGRONIMERS FOR TARGET PROTEIN DEGRADATION | C4 THERAPEUTICS, INC. (US) | 2025-02-20 | — | — | US | disclosed |
| US-4874546-A | LIQUID CRYSTALS | CHISSO CORPORATION (JP) | 1989-10-17 | — | — | US | disclosed |
| US-4598149-A | ADRENERGIC BLOCKING AGENTS | MERCK & CO., INC. (US) | 1986-07-01 | — | — | US | disclosed |
| EP-0153746-A2 | 3-Amino-2-hydroxypropyl derivatives of pyrimidin-4-one | MERCK & CO. INC. (US) | 1985-09-04 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250057957-A1 | SPIROCYCLIC DEGRONIMERS FOR TARGET PROTEIN DEGRADATION | STUB1, UBE3C, UBE3A | PRSS1 2385/4885PRSS2 3295/4885PRSS3 3209/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.